Umberto Pensato on Cancer and Stroke
Umberto Pensato, Assistant Professor of Neurology at the Humanitas University, Research Collaborator at the University of Calgary, shared on LinkedIn:
”Stroke in patients with cancer is common (1 every 7 patients), yet it is becoming extremely challenging to understand patient prognosis and goal-of-care, especially in the time-pressured environment of acute stroke care, resulting in missed/delayed acute treatment (not really in keeping with “Time is Brain”).
This is a call for oncologists, please provide upfront: (i)life expectancy (> or < 6 months?), (ii) goal-of-care (resuscitate, medical or comfort?), and (iii) intent of oncologist treatment (curative or palliative). Help us treat these patients better and faster
Take a look at our viewpoint in JAMA Oncology, Ronda Lun, Jeffrey Q Cao, and Andrew Demchuk, Humanitas University, University of Calgary”
Read the full article here.
Article: Stroke in Patients With Cancer—Time Is Brain
Authors: Ronda Lun, Jeffrey Q Cao, Andrew Demchuk, Umberto Pensato
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin